Series A - Arch Oncology
Investment Firm
Overview
Arch Oncology is a venture-stage biopharmaceutical company.
Announced Date
Aug 16, 2016
Closed on Date
Aug 01, 2016
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Roche Venture Fund
Roche Venture Fund is a early_stage_venture and late_stage_venture firm.
RiverVest
RiverVest is a early_stage_venture and late_stage_venture and post_ipo and venture firm.
SR One
SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Novo Ventures
Novo Ventures is a early_stage_venture and late_stage_venture firm.
Participant Investors
5
Round Details and Background
Arch Oncology raised $86000000 on 2016-08-16 in Series A
Arch Oncology is a venture-stage biopharmaceutical company.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 27, 2021 |  Series C - Arch Oncology | 11 | - | 105.0M |
| Aug 16, 2016 | Series A - Arch Oncology | 5 | - | 86.0M |
| Aug 10, 2015 | Venture Round - Arch Oncology | 1 | - | 8.1M |
| Feb 12, 2015 | Venture Round - Arch Oncology | - | 1.3M |
Recent Activity
There is no recent news or activity for this profile.